Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Mr Pedro Marques Vidal
Determinants and prevalence of e-cigarette use throughout the European Union: a secondary analysis of 26 566 youth and adults from 27 Countries.Vardavas CI et al.Tob Control. Published online 16 June 2014. doi: 10.1136/tobaccocontrol-2013-051394
Electronic cigarettes (e-cigarettes) have become a fashionable alternative to “common” cigarette smoking, but little information existed regarding their use and knowledge in Europe.In the largest ever European study regarding knowledge and use of e-cigarette, Vardavas and colleagues reported that over two thirds of Europeans have heard of e-cigarettes, but a lower percentage knows what they are, and a sizable fraction (between 14 and 47% depending on country) does not know if they are harmful. The authors estimated that over 23 million Europeans have used or experimented e-cigarettes. Subjects aged less than 40, smokers who attempted to quit and heavy smokers were most likely to use or experiment e-cigarettes.These findings stress the need to evaluate the health impact of e-cigarettes: although heavy smokers might use e-cigarettes to reduce or quit smoking, e-cigarettes can also be a novel and fashionable method of entering tobacco addiction. Thus, EU-based regulations are urgently needed.
© 2017 European Society of Cardiology. All rights reserved